BioCentury
ARTICLE | Clinical News

Celtrix regulatory update

March 29, 1993 8:00 AM UTC

Celtrix Pharmaceuticals Inc. (CTRX) Celtrix Pharmaceuticals Inc. (CTRX) received U.S. patent No. 5,200,509 covering the composition of the physiological binding protein IGF-BP3 for insulin-like growt...